dental and medical devices
CAPZA has been supporting the external growth strategy of ACTEON through a flexible and reactive private debt offering.
ACTEON creates, develops and distributes high-tech dental and medical devices that enable dentists and surgeons to implement less invasive, safer and quicker operating protocols that are less traumatic for their patients. Based in Merignac near Bordeaux, the group employs almost 750 people and is represented in over 100 countries worldwide.
ACTEON, a leader in high frequency ultrasonics and digital medical imaging, is split into 4 business units: dental equipment, medical equipment, imaging and pharma. Boasting significant technical know-how, ACTEON ’s products are renowned by practitioners for their quality, reliability and innovation. ACTEON employs highly trained technical and sales teams and has set up a powerful distribution network worldwide.
Context & Ambition
In 2016, the Group was looking for a partner to finance a new LBO as well as potential acquisitions as Bridgepoint took over the group alongside the management team. The group wanted to speed up its development by expanding the sales team, broadening the product range and extending its geographic footprint through external growth. In 2018, Bridgepoint sold its equity stake to Dentressangle.
In 2016, CAPZA arranged the initial debt financing when Bridgepoint acquired the group alongside the management team.
The unitranche facility also included an acquisition facility, which was drawn in 2017, as Acteon acquired Prodont Holliger, an expert in dental manual instruments. In 2018, we financed Dentressangle’s acquisition and the subsequent development strategy. The group aims to enter the top 5 worldwide for dental imaging and strives to equip 33% of dental practices with ultrasonic surgical devices.
16Sep’ 2021CAPZA Expansion supports Big Mamma in its development in France and in EuropeCAPZA Expansion and Zencap are supporting the French group of Italian restaurants Big Mamma.Read more
22Jul’ 2021CAPZA Expansion invests in the French industrial group NovarcCAPZA Expansion enters the capital of Novarc to back the Group in its "CAP 2025" strategic plan.Read more
21Jul’ 2021CAPZA Transition supports the NORCAN groupCAPZA Transition reinforces the transformation of the NORCAN Group and the development of the SHERPA® range alongside its management and its historical shareholdersRead more
15Jul’ 2021CAPZA exits Ivnosys after supporting the group's growthCAPZA sold its minority stake in Ivnosys, a Spanish leading e-identity company.Read more